X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (468) 468
Publication (83) 83
Patent (25) 25
Book Chapter (3) 3
Book / eBook (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (249) 249
female (230) 230
oncology (184) 184
middle aged (176) 176
breast cancer (127) 127
breast neoplasms - drug therapy (110) 110
aged (104) 104
index medicus (104) 104
breast neoplasms - pathology (101) 101
adult (90) 90
antineoplastic combined chemotherapy protocols - therapeutic use (88) 88
chemotherapy (88) 88
chemotherapy, adjuvant (80) 80
cancer (76) 76
disease-free survival (73) 73
breast neoplasms - surgery (67) 67
treatment outcome (61) 61
follow-up studies (56) 56
neoplasm staging (56) 56
prognosis (56) 56
tamoxifen (56) 56
fluorouracil - administration & dosage (54) 54
tamoxifen - therapeutic use (54) 54
clinical trials (53) 53
male (53) 53
surgery (53) 53
lymphatic metastasis (51) 51
therapy (50) 50
breast neoplasms - mortality (48) 48
article (45) 45
combined modality therapy (42) 42
survival analysis (42) 42
cyclophosphamide - administration & dosage (39) 39
mastectomy (36) 36
surgical adjuvant breast (36) 36
doxorubicin - administration & dosage (35) 35
research (35) 35
risk factors (35) 35
randomized controlled trials as topic (34) 34
antineoplastic combined chemotherapy protocols - adverse effects (33) 33
care and treatment (33) 33
fluorouracil (32) 32
radiotherapy (31) 31
risk (31) 31
survival (31) 31
women (31) 31
colonic neoplasms - pathology (30) 30
medicine, general & internal (30) 30
original reports (30) 30
antineoplastic agents, hormonal - therapeutic use (29) 29
breast neoplasms - radiotherapy (29) 29
colonic neoplasms - drug therapy (29) 29
clinical trials as topic (28) 28
tumors (27) 27
carcinoma (26) 26
radiation-therapy (26) 26
adjuvant treatment (25) 25
human necessities (25) 25
hygiene (25) 25
mastectomy, segmental (25) 25
medical or veterinary science (25) 25
time factors (25) 25
leucovorin - administration & dosage (24) 24
proportional hazards models (24) 24
breast neoplasms - prevention & control (23) 23
survival rate (23) 23
breast neoplasms - metabolism (22) 22
breast neoplasms - therapy (22) 22
cancer therapies (22) 22
drug therapy (22) 22
health aspects (22) 22
neoplasm recurrence, local (22) 22
prospective studies (22) 22
tamoxifen - administration & dosage (22) 22
trial (22) 22
patient outcomes (21) 21
diagnosis (20) 20
quality of life (20) 20
recurrence (20) 20
risk assessment (20) 20
trastuzumab (20) 20
antineoplastic combined chemotherapy protocols - administration & dosage (19) 19
lymph nodes - pathology (19) 19
medicine & public health (19) 19
random allocation (19) 19
breast (18) 18
incidence (18) 18
leucovorin (18) 18
postmenopausal women (18) 18
randomized-trial (18) 18
aged, 80 and over (17) 17
breast neoplasms - chemistry (17) 17
colonic neoplasms - mortality (17) 17
colorectal cancer (17) 17
evaluation (17) 17
lumpectomy (17) 17
neoplasm invasiveness (17) 17
prevention (17) 17
receptors, estrogen - analysis (17) 17
receptors, estrogen - metabolism (17) 17
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (497) 497
French (10) 10
Spanish (4) 4
German (3) 3
Chinese (2) 2
Arabic (1) 1
Czech (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9938, pp. 164 - 172
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2008, Volume 358, Issue 13, pp. 1409 - 1411
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 927 - 933
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 12, pp. 1183 - 1192
Summary Background We studied the effect on tumour response to neoadjuvant therapy of the substitution of lapatinib for trastuzumab in combination with weekly... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | WOMEN | CELLS | SURGICAL ADJUVANT BREAST | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | GW572016 | CHEMOTHERAPY PLUS TRASTUZUMAB | PERTUZUMAB | INHIBITOR | DOCETAXEL | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Puerto Rico | United States | Humans | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Breast Neoplasms - enzymology | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Mastectomy | Female | Neoadjuvant Therapy | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Drug Administration Schedule | Logistic Models | Treatment Outcome | Chi-Square Distribution | Breast Neoplasms - drug therapy | Canada | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | Quinazolines - adverse effects | Trastuzumab | Health maintenance organizations | Neoadjuvant therapy | Medical colleges | Care and treatment | Cyclophosphamide | Anthracyclines | Adjuvant treatment | Breast cancer | Product development | Public health | Cancer | Index Medicus
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10021, pp. 849 - 856
Summary Background Ductal carcinoma in situ is currently managed with excision, radiotherapy, and adjuvant hormone therapy, usually tamoxifen. We postulated... 
Internal Medicine | INTRADUCTAL BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | SURGICAL ADJUVANT BREAST | RADIATION-THERAPY | B-17 | Breast Neoplasms - surgery | Triazoles - administration & dosage | Triazoles - adverse effects | Thrombosis - chemically induced | Age Factors | Humans | Middle Aged | Tamoxifen - administration & dosage | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Carcinoma, Ductal, Breast - drug therapy | Mastectomy, Segmental | Antineoplastic Agents, Hormonal - therapeutic use | Postmenopause | Female | Embolism - chemically induced | Aromatase Inhibitors - therapeutic use | Triazoles - therapeutic use | Aromatase Inhibitors - administration & dosage | Carcinoma, Ductal, Breast - surgery | Double-Blind Method | Administration, Oral | Antineoplastic Agents, Hormonal - administration & dosage | Combined Modality Therapy | Breast Neoplasms - drug therapy | Breast Neoplasms - radiotherapy | Carcinoma, Ductal, Breast - radiotherapy | Tamoxifen - therapeutic use | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Lumpectomy | Medical colleges | Carcinoma | Radiation | Clinical trials | Postmenopausal women | Hormones | Tamoxifen | Radiotherapy | Biometry | Health maintenance organizations | Product development | Cancer | Chemotherapy | Womens health | Older people | Breast cancer | Radiation therapy | Cancer surgery
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2011, Volume 29, Issue 25, pp. 3366 - 3373
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1037 - 1048
Journal Article